Oxidative stress, molecular inflammation and sarcopenia

Si-Jin Meng, Long-Jiang Yu, Si-Jin Meng, Long-Jiang Yu

Abstract

Sarcopenia is the decline of muscle mass and strength with age. Evidence suggests that oxidative stress and molecular inflammation play important roles in age-related muscle atrophy. The two factors may interfere with the balance between protein synthesis and breakdown, cause mitochondrial dysfunction, and induce apoptosis. The purpose of this review is to discuss some of the major signaling pathways that are activated or inactivated during the oxidative stress and molecular inflammation seen in aged skeletal muscle. Combined interventions that may be required to reverse sarcopenia, such as exercise, caloric restriction, and nutrition, will also be discussed.

Keywords: chronic inflammation; interventions; oxidative stress; sarcopenia; signaling.

Figures

Figure 1.
Figure 1.
A schematic summary of proposed mechanisms by which oxidative stress and chronic inflammation could contribute to sarcopenia. Some major signaling pathways are activated or inactivated during the oxidative stress and chronic inflammation seen in aged skeletal muscle. The pathways are related to an imbalance of protein synthesis and breakdown, mitochondrial dysfunction, and apoptosis, leading to fiber atrophy and fiber loss, eventually to sarcopenia.
Figure 2.
Figure 2.
Hypothetical scheme for how combined interventions can affect sarcopenia.

References

    1. Rosenberg IH. Sarcopenia: Origins and clinical relevance. J. Nutr. 1997;127:990S–991S.
    1. Faulkner JA, Larkin LM, Claflin DR, Brooks SV. Age-related changes in the structure and function of skeletal muscles. Clin. Exp. Pharmacol. Physiol. 2007;34:1091–1096.
    1. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 2004;52:80–85.
    1. Daw CK, Starnes JW, White TP. Muscle atrophy and hypoplasia with aging: Impact of training and food restriction. J. Appl. Physiol. 1988;64:2428–2432.
    1. Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J. Neurol. Sci. 1988;84:275–294.
    1. Carter CS, Hofer T, Seo AT, Leeuwenburgh C. Molecular mechanisms of life- and health-span extension: Role of calorie restriction and exercise intervention. Appl. Physiol. Nutr. Metab. 2007;32:954–966.
    1. Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292:R18–R36.
    1. Siu PM, Pistilli EE, Alway SE. Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading. J. Appl. Physiol. 2008;105:1695–705.
    1. Moylan JS, Reid MB. Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve. 2007;35:411–429.
    1. Samba RD, Lauretani F, Ferrucci L. Carotenoids as protection against sarcopenia in older adults. Arch. Biochem. Biophys. 2007;458:141–145.
    1. Howard C, Ferrucci L, Sun K, Fried LP, Walston J, Varadhan R, Guralnik JM, Semba RD. Oxidative protein damage is associated with poor grip strength among older women living in the community. J. Appl. Physiol. 2007;103:17–20.
    1. Koopman R, van Loon LJ. Aging, exercise and muscle protein metabolism. J. Appl. Physiol. 2009;106:2040–2048.
    1. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009;8:18–30.
    1. Reid MB, Li YP. Tumor necrosis factor-α and muscle wasting: A cellular perspective. Respir. Res. 2001;2:269–272.
    1. Brinkley TE, Leng X, Miller ME, Kitzman DW, Pahor M, Berry MJ, Marsh AP, Kritchevsky SB, Nicklas BJ. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J. Gerontol. A. Biol. Sci. Med. Sci. 2009;64:455–461.
    1. Toth MJ, Matthews DE, Tracy RP, Previs MJ. Age-related differences in skeletal muscle protein synthesis: Relation to markers of immune activation. Am. J. Physiol. Endocrinol. Metab. 2005;288:E883–E891.
    1. Roubenoff R. Catabolism of aging: Is it an inflammatory process? Curr. Opin. Clin. Nutr. Metab. Care. 2003;6:295–299.
    1. Bua E, Johnson J, Herbst A, Delong B, McKenzie D, Salamat S, Aiken JM. Mitochondrial DNA–deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. Am. J. Hum. Genet. 2006;79:469–480.
    1. Mariappan N, Elks CM, Fink B, Francis J. TNF-induced mitochondrial damage: A link between mitochondrial complex I activity and left ventricular dysfunction. Free Radic Biol. Med. 2009;46:462–470.
    1. Figueiredo PA, Mota MP, Appell HJ, Duarte JA. The role of mitochondria in aging of skeletal muscle. Biogerontology. 2008;9:67–84.
    1. Marzetti E, Wohlgemutz SE, Lees HA, Chung H, Giovannini S, Leeuwenburgh C. Age-related activation of mitochondrial caspase-independent apoptotic signaling in rat gastrocnemius muscle. Mech. Ageing Dev. 2008;129:542–549.
    1. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulous GD, Glass DJ. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 2001;3:1009–1013.
    1. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL. IGF-1 stimulates muscle growth by suppressing protein breakdown and expression of atrphy-related ubiquitin-ligases, atrogin-1 and MuRF1. Am. J. Physiol. Endocrinol. Metab. 2004;287:E591–E601.
    1. Li M, Li C, Parkhouse WS. Age-related differences in the des IGF-I-mediated activation of Akt-1 and p70 S6K in mouse skeletal muscle. Mech. Ageing Dev. 2003;124:771–778.
    1. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ. Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol. Cell Biol. 2004;24:9295–9304.
    1. Léger B, Cartoni R, Praz M, Lamon S, Dériaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F, et al. Akt signaling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J. Physiol. 2006;576:923–933.
    1. Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulous GD, Glass DJ. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J. Biol. Chem. 2005;280:2737–2744.
    1. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biol. 2001;3:1014–1019.
    1. Bodine SC. mTOR signaling and the molecular adaptation to resistance exercise. Med. Sci. Sprots Exerc. 2006;38:1950–1957.
    1. Koopman R, Zorenc AH, Gransier RJ, Cameron-Smith D, van Loon LJ. Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type II muscle fibers. Am. J. Physiol. Endocrinol. Metab. 2006;290:E1245–E1252.
    1. Owino V, Yang SY, Goldspink G. Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett. 2001;505:259–263.
    1. Haddad F, Adams GR. Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy. J. Appl. Physoil. 2006;100:1188–1203.
    1. O’Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW. Regulation of IGF-I Function by Proinflammatory Cytokines: At the Interface of Immunology and Endocrinology. Cell Immunol. 2008;252:91–110.
    1. Papaconstantinou J. Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination. Mol. Cell Endocrinol. 2009;299:89–100.
    1. Grounds MD, Radley HG, Gebski BG, Bogoyevitch MA, Shavlakadze T. Implications of cross-talk between TNF and IGF-1 signalling in skeletal muscle. Proc. Aust. Physiol. Soci. 2008;39:7–13.
    1. Thomson DM, Gordon SE. Impaired overload-induced muscle growth is associated with diminished translational signaling in aged rat fast-twitch skeletal muscle. J. Physiol. 2006;574:291–305.
    1. Funai F, Parkington JD, Carambula S, Fielding RA. Age associated decrease in contraction-induced activation of downstream targets of Akt/mTOR signaling in skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006;290:R1080–R1086.
    1. Léger B, Bock KD, Hespel P, Russell AP. Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of akt phosphorylation. Rejuv. Res. 2008;11:163–175.
    1. Marzani B, Balage M, Vénien A, Astruc T, Papet I, Dardevet D, Mosoni L. Antioxidant Supplementation Restores Defective Leucine Stimulation of Protein Synthesis in Skeletal Muscle from Old Rats. J. Nutr. 2008;138:2205–2211.
    1. Furukawa-Hibi Y, Kobayashi Y, Chen C, Motoyama N. FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxid Redox Signal. 2005;7:752–760.
    1. Southgate RJ, Neill B, Prelovsek O, El-Osta A, Kamei Y, Miura S, Ezaki O, McLoughlin TJ, Zhang W, Unterman TG. FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. J. Biol. Chem. 2007;282:21176–21186.
    1. Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, Mochida K, Hata T, Matsuda J, Aburatani H, et al. Skeletal muscle FOXO1(FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch /red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 2004;279:41114–41123.
    1. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell. 2004;14:395–403.
    1. Welle S, Brooks AI, Delehanty JM, Needler N, Thornton CA. Gene expression profile of aging in human muscle. Physiol. Genomics. 2003;14:149–159.
    1. Machida S, Booth FW. Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp. Gerontol. 2004;39:1521–1525.
    1. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004;117:399–412.
    1. Giresi PG, Stevenson EJ, Theilhaber J, Koncarevic A, Parkington J, Fielding RA, Kandarian SC. Identification of a molecular signature of sarcopenia. Physiol. Genomics. 2005;21:253–263.
    1. Piette J, Piret B, Bonizzi G, Schoonbroodt S, Merville MP, Legrand-Poels S, Bours V. Multiple redox regulation in NF-κB transcription factor activation. Biol Chem. 1997;378:1, 237–1245.
    1. Dogra C, Changotra H, Mohan S, Kumar A. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J. Biol. Chem. 2006;281:10327–10336.
    1. Mourkioti F, Kratsios P, Luedde T, Song Y, Delafontaine P, Adami R, Parente V, Bottinelli R, Pasparakis M, Rosenthal N. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J. Clin. Invest. 2006;116:2945–2954.
    1. Hunter RB, Kandarian SC. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J. Clin. Invest. 2004;114:1504–1511.
    1. Urso ML, Chen YW, Scrimgeour AG, Lee PC, Lee KF, Clarkson PM. Alterations in mRNA expression and protein products following spinal cord injury in humans. J. Physiol. 2007;579:877–892.
    1. Cuthbertson D, Smith K, Babraj J, Leese G, Waddell T, Atherton P, Wackerhage H, Taylor PM, Rennie MJ. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 2005;19:422–424.
    1. Phillips T, Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-α signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J. 2005;19:668–670.
    1. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J. 2005;19:362–370.
    1. Gredinger E, Gerber A, Tamir Y, Tapscott S, Bengal E. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J. Biol. Chem. 1998;273:10436–10444.
    1. Musaro A, De Angelis C, Germani A, Ciccarelli C, Molinaro M, Zani B. Enhanced expression of myogenic regulatory genes in aging skeletal muscle. Exp. Cell Res. 1995;221:241–248.
    1. Williamson D, Gallagher P, Harber M, Hollon C, Trappe S. Mitogen-activated protein kinase (MAPK) pathway activation: Effects of age and acute exercise on human skeletal muscle. J. Physiol. 2003;547:977–987.
    1. Drummond MJ, Dreyer HC, Pennings B, Fry CS, Dhanani S, Dillon EL, Sheffield-Moore M, Volpi E, Rasmussen BB. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J. Appl. Physiol. 2008;104:1452–1461.
    1. Raingeaud J, Gupta S, Rogers J, Dickens M, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 1995;270:7420–7426.
    1. Shen HM, Liu ZG. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 2006;40:928–939.
    1. Braga M, Sinha-Hikim AP, Datta S, Ferrini MG, Brown D, Kovacheva EL, Gonzalez-Cadavid NF, Sinha-Hikim I. Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis. 2008;13:822–832.
    1. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 2005;37:1974–1984.
    1. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001;294:1704–1708.
    1. Li HH, Kedar V, Zhang C, Arya R, Wang DZ, Patterson C. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J. Clin. Invest. 2004;114:1058–1071.
    1. Stitt TN, Drujan D, Clarke BA, Panaro FJ, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell. 2004;14:395–403.
    1. Cai D, Frantz JD, Tawa NE, Jr, Melendez PA, Oh B, Lidov HGW, Hasselgren P, Frontera WR, Lee J, Glass DJ, et al. IKKb/NF-kB activation causes severe muscle wasting in mice. Cell. 2004;119:285–298.
    1. Clavel S, Coldefy AS, Kurkdjian E, Salles J, Margaritis I, Derijard B. Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat tibialis anterior muscle. Mech. Ageing Dev. 2006;127:794–801.
    1. Edstrom E, Altun M, Hagglund M, Ulfhake B. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J. Gerontol. A: Biol. Sci. Med. Sci. 2006;61:663–674.
    1. Whitman SA, Wacker MJ, Richmond SR, Godard MP. Contributions of the ubiquitin-proteasome pathway and apoptosis to human skeletal muscle wasting with age. Pflugers Arch. 2005;450:437–446.
    1. Raue U, Slivka D, Jemiolo B, Hollon C, Trappe S. Proteolytic gene expression differs at rest and after resistance exercise between young and old women. J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:1407–1412.
    1. Christoph H, Spiegelman M. The role of exercise and PGC1α in inflammation and chronic disease. Nature. 2008;454:463–469.
    1. Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: The central role of PGC-1α. Cardiovasc. Res. 2008;79:208–217.
    1. Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, Goldberg AL, Spiegelman BM. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. USA. 2006;103:16260–16265.
    1. Handschin C, Kobayashi YM, Chin S, Seale P, Campbell KP, Spiegelman BM. PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev. 2007;21:770–783.
    1. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin K, Yang W, et al. Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators. Cell. 2006;127:397–408.
    1. Hood DA, Irrcher I, Ljubicic V, Joseph AM. Coordination of metabolic plasticity in skeletal muscle. J. Exp. Bio. 2006;209:2265–2275.
    1. Jager S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA. 2007;104:12017–12022.
    1. Chabi B, Ljubicic V, Menzies KJ, Huang JH, Sallem A, Hood DA. Mitochondrial function and apoptotic susceptibility in aging skeletal muscle. Aging Cell. 2008;7:2–12.
    1. López-Lluch G, Irusta PM, Navas P, de Cabo R. Mitochondrial biogenesis and healthy aging. Exp. Gerontol. 2008;43:813–819.
    1. Leeuwenburgh C. Role of apoptosis in sarcopenia. J. Gerontol. Med. Sci. 2003;58:999–1001.
    1. Nitahara JA, Cheng W, Liu Y, Li B, Leri A, Mogul D, Gambert SR, Kajstura J, Anversa P. Intracellular calcium, DNase activity and myocyte apoptosis in aging Fischer 344 rats. J. Mol. Cell. Cardiol. 1998;30:519–535.
    1. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad. Biol. Med. 2000;29:222–230.
    1. Song W, Kwak H, Lawler JM. Exercise training attenuates age-induced changes in apoptotic signaling in rat skeletal muscle. Antioxid. Redox. Signal. 2006;8:517–528.
    1. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J. 2001;15:475–482.
    1. Menshikova EV, Ritov VB, Fairfull L, Ferrell RE, Kelley DE, Goodpaster BH. Effects of Exercise on Mitochondrial Content and Function in Aging Human Skeletal Muscle. J. Gerontol. A: Biol. Sci. Med. Sci. 2006;61:534–540.
    1. Russell AP, Schreiber S, Crettenand A, Meier CA, Kralli A, Deriaz O. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes. 2003;52:2874–2881.
    1. Gleeson M, McFarlin B, Flynn M. Exercise and Toll-like receptors. Exerc. Immunol. Rev. 2006;12:34–53.
    1. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J. Appl. Physiol. 2005;98:1154–1162.
    1. Hameed M, Orrell RW, Cobbold M, Goldspink G, Harridge SD. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J. Physiol. 2003;547:247–254.
    1. Kosek DJ, Kim J, Petrella JK, Cross JM, Bamman MM. Efficacy of 3 days/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. older adults. J. Appl. Physiol. 2006;101:531–544.
    1. Melov S, Tarnopolsky MA, Beckman K, Felkey K, Hubbard A. Resistance exercise reverses aging in human skeletal muscle. PLoS ONE. 2007;2:e465.
    1. Sillanpää E, Häkkinen A, Nyman K, Mattila M, Cheng S, Karavirta L, Laaksonen DE, Huuhka N, Kraemer WJ, Häkkinen K. Body Composition and Fitness during Strength and/or Endurance Training in Older Men. Med. Sci. Sports Exerc. 2008;40:950–958.
    1. Nader GA. Concurrent strength and endurance training: From molecules to man. Med. Sci. Sports Exerc. 2006;38:1965–1970.
    1. Atherton PJ, Babraj J, Smith K, Singh J, Rennie MJ, Wackerhage H. Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J. 2005;19:786–798.
    1. Leeuwenburgh C, Wagner P, Holloszy JO, Sohal RS, Heinecke JW. Caloric restriction attenuates dityrosine cross-linking of cardiac and skeletal muscle proteins in aging mice. Arch. Biochem. Biophys. 1997;346:74–80.
    1. McKiernan S, Bua E, McGorray J, Aiken J. Early-onset calorie restriction conserves fiber number in aging rat skeletal muscle. FASEB J. 2004;18:580–581.
    1. Kim J, Kwak H, Leeuwenburgh C, Lawler JM. Lifelong Exercise and Mild (8%) Caloric Restriction Attenuate Age-induced Alterations in Plantaris Muscle Morphology, Oxidative Stress and IGF-1 in the Fischer-344 Rat. Exp. Gerontol. 2008;43:317–329.
    1. Dreyer HC, Volpi E. Role of protein and amino acids in the pathophysiology and treatment of sarcopenia. J. Am. Coll. Nutr. 2005;24:140S–145S.
    1. Fujita S, Dreyer HC, Drummond MJ, Glynn EL, Cadenas JG, Yoshizawa F, Volpi E, Rasmussen BB. Nutrient signalling in the regulation of human muscle protein synthesis. J. Physiol. 2007;582:813–823.
    1. Karlsson HK, Nilsson PA, Nilsson J, Chibalin AV, Zierath JR, Blomstrand E. Branched-chain amino acids increase p70S6k phosphorylation in human skeletal muscle after resistance exercise. Am. J. Physiol. 2004;287:E1–E7.
    1. Zangarelli A, Chanseaume E, Morio B, Brugère C, Mosoni L, Rousset P, Giraudet C, Patrac V, Gachon P, Boirie Y, et al. Synergistic effects of caloric restriction with maintained protein intake on skeletal muscle performance in 21-month-old rats: A mitochondria-mediated pathway. FASEB J. 2006;20:2439–2450.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi